UBS keeps Intuitive Surgical target at USD 500.00; stock pre-market at EUR 377.15
Published on 10/14/2026 at 08:15 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst view and trading agenda
- UBS maintained a Buy rating and a USD 500.00 target on October 13, 2026.
- Intuitive Surgical stock trades pre-market at EUR 377.15 at 8:12 a.m. CEST at Lang & Schwarz on October 14, 2026.
- The company is scheduled to report third-quarter results after market close on October 20, 2026.
UBS maintained a Buy rating and a USD 500.00 price target for Intuitive Surgical on October 13, 2026, ahead of the company’s scheduled third-quarter earnings report. Intuitive Surgical stock trades pre-market at EUR 377.15 at Lang & Schwarz at 8:12 a.m. CEST on October 14, 2026. The quote is stated separately from the analyst note. Investing.com reported the UBS view.
Pre-market trading
Lang & Schwarz showed a bid of EUR 375.30 and an ask of EUR 379.00 on October 14, 2026. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Intuitive Surgical stock.
What matters today
Intuitive Surgical’s next scheduled company date is October 20, 2026, when third-quarter results are expected after the market close. A round-number reference of EUR 400.00 is 6.06 percent above the current EUR 377.15 quote. UBS’s latest target is USD 500.00, maintained with its Buy rating on October 13, 2026. The earnings date and analyst view were reported by MarketBeat and Investing.com.
Market context: Market report Nasdaq Composite.
